Citation: P. Svarvar et A. Aly, Use of the ACCES model to predict the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis in Norway, RHEUMATOLOG, 39, 2000, pp. 43-50
Citation: U. Haglund et P. Svarvar, The Swedish ACCES model: predicting the health economic impact of celecoxib in patients with osteoarthritis or rheumatoid arthritis, RHEUMATOLOG, 39, 2000, pp. 51-56
Citation: A. Anell et P. Svarvar, Pharmacoeconomics and clinical practice guidelines - A survey of attitudesin Swedish formulary committees, PHARMACOECO, 17(2), 2000, pp. 175-185